Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line

Introduction

The Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and applications of the epidermal growth factor receptor (EGFR). This cell line is derived from human embryonic kidney cells (HEK293T) and stably expresses the EGFR protein, also known as ERBB1 or HER1. This article will provide a comprehensive overview of this cell line, including its structure, activity, and potential applications in research and therapeutics.

Structure of Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line

The Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line is a clonal cell line that has been genetically modified to express the human EGFR protein. The EGFR protein is a transmembrane receptor that belongs to the ErbB family of receptor tyrosine kinases. It is composed of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain contains the ligand-binding site, while the intracellular domain has tyrosine kinase activity.
The HEK293T cells used to generate this stable cell line are a commonly used cell line in research due to their high transfection efficiency and ability to express exogenous proteins. The stable expression of EGFR in these cells allows for consistent and reliable results in experiments.

Activity of Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line

The Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line is a valuable tool for studying the activity of EGFR. This cell line can be used to investigate the binding and activation of EGFR by its ligands, such as epidermal growth factor (EGF). The ligand-binding site on the extracellular domain of EGFR binds to EGF, leading to the activation of the intracellular tyrosine kinase domain and subsequent downstream signaling pathways.
In addition, this cell line can be used to study the effects of EGFR inhibitors, such as small molecule inhibitors or monoclonal antibodies, on EGFR signaling. These inhibitors can block the activation of EGFR and its downstream signaling, providing insights into the role of EGFR in various cellular processes.
Flow cytometry is a commonly used technique to analyze the activity of EGFR in this stable cell line. By labeling the cells with fluorescently tagged EGF, researchers can measure the binding and activation of EGFR using flow cytometry. This allows for a quantitative analysis of EGFR activity in response to different treatments or conditions.

Applications of Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line

The Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line has a wide range of applications in both research and therapeutics. In research, this cell line can be used to study the role of EGFR in various cellular processes, such as cell proliferation, survival, and differentiation. It can also be used to investigate the mechanisms of action of EGFR inhibitors and their potential therapeutic applications.
In therapeutics, the Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line can be used as a model system for drug screening and development. By testing potential EGFR inhibitors on this cell line, researchers can identify promising candidates for further development as anti-cancer drugs. In addition, this cell line can be used to study drug resistance mechanisms in cancer cells that overexpress EGFR.

Conclusion

The Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and applications of EGFR. Its stable expression of EGFR allows for consistent and reliable results in experiments, and it can be used in a variety of research and therapeutic applications.